245 related articles for article (PubMed ID: 22711709)
21. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.
Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB
Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247
[TBL] [Abstract][Full Text] [Related]
22. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
[TBL] [Abstract][Full Text] [Related]
23. Fluorescence-based assays for the assessment of drug interaction with the human transporters OATP1B1 and OATP1B3.
Bednarczyk D
Anal Biochem; 2010 Oct; 405(1):50-8. PubMed ID: 20540932
[TBL] [Abstract][Full Text] [Related]
24. Screening of antibiotics that interact with organic anion-transporting polypeptides 1B1 and 1B3 using fluorescent probes.
Yamaguchi H; Takeuchi T; Okada M; Kobayashi M; Unno M; Abe T; Goto J; Hishinuma T; Shimada M; Mano N
Biol Pharm Bull; 2011; 34(3):389-95. PubMed ID: 21372390
[TBL] [Abstract][Full Text] [Related]
25. Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3.
Noé J; Portmann R; Brun ME; Funk C
Drug Metab Dispos; 2007 Aug; 35(8):1308-14. PubMed ID: 17470528
[TBL] [Abstract][Full Text] [Related]
26. Pre-incubation with OATP1B1 and OATP1B3 inhibitors potentiates inhibitory effects in physiologically relevant sandwich-cultured primary human hepatocytes.
Farasyn T; Pahwa S; Xu C; Yue W
Eur J Pharm Sci; 2021 Oct; 165():105951. PubMed ID: 34311070
[TBL] [Abstract][Full Text] [Related]
27. Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination.
Smith NF; Figg WD; Sparreboom A
Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):429-45. PubMed ID: 16863454
[TBL] [Abstract][Full Text] [Related]
28. HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms.
Hartkoorn RC; Kwan WS; Shallcross V; Chaikan A; Liptrott N; Egan D; Sora ES; James CE; Gibbons S; Bray PG; Back DJ; Khoo SH; Owen A
Pharmacogenet Genomics; 2010 Feb; 20(2):112-20. PubMed ID: 20051929
[TBL] [Abstract][Full Text] [Related]
29. The impact of Organic Anion-Transporting Polypeptides (OATPs) on disposition and toxicity of antitumor drugs: Insights from knockout and humanized mice.
Durmus S; van Hoppe S; Schinkel AH
Drug Resist Updat; 2016 Jul; 27():72-88. PubMed ID: 27449599
[TBL] [Abstract][Full Text] [Related]
30. OATP1B3 Expression and Function is Modulated by Coexpression with OCT1, OATP1B1, and NTCP.
Zhang Y; Ruggiero M; Hagenbuch B
Drug Metab Dispos; 2020 Aug; 48(8):622-630. PubMed ID: 32482756
[TBL] [Abstract][Full Text] [Related]
31. Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake.
Niemi M; Pasanen MK; Neuvonen PJ
Pharmacol Rev; 2011 Mar; 63(1):157-81. PubMed ID: 21245207
[TBL] [Abstract][Full Text] [Related]
32. Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.
Kunze A; Huwyler J; Camenisch G; Poller B
Drug Metab Dispos; 2014 Sep; 42(9):1514-21. PubMed ID: 24989890
[TBL] [Abstract][Full Text] [Related]
33. The role of OATP1B1 and OATP1B3 transporter polymorphisms in drug disposition and response to anticancer drugs: a review of the recent literature.
Anabtawi N; Drabison T; Hu S; Sparreboom A; Talebi Z
Expert Opin Drug Metab Toxicol; 2022; 18(7-8):459-468. PubMed ID: 35983889
[TBL] [Abstract][Full Text] [Related]
34. Organic Anion Transporting Polypeptide-Mediated Hepatic Uptake of Glucuronide Metabolites of Androgens.
Li CY; Gupta A; Gáborik Z; Kis E; Prasad B
Mol Pharmacol; 2020 Sep; 98(3):234-242. PubMed ID: 32587096
[TBL] [Abstract][Full Text] [Related]
35. Transport by OATP1B1 and OATP1B3 enhances the cytotoxicity of epigallocatechin 3-O-gallate and several quercetin derivatives.
Zhang Y; Hays A; Noblett A; Thapa M; Hua DH; Hagenbuch B
J Nat Prod; 2013 Mar; 76(3):368-73. PubMed ID: 23327877
[TBL] [Abstract][Full Text] [Related]
36. In vivo disposition of doxorubicin is affected by mouse Oatp1a/1b and human OATP1A/1B transporters.
Durmus S; Naik J; Buil L; Wagenaar E; van Tellingen O; Schinkel AH
Int J Cancer; 2014 Oct; 135(7):1700-10. PubMed ID: 24554572
[TBL] [Abstract][Full Text] [Related]
37. OATP1B1/1B3 activity in plated primary human hepatocytes over time in culture.
Ulvestad M; Björquist P; Molden E; Asberg A; Andersson TB
Biochem Pharmacol; 2011 Nov; 82(9):1219-26. PubMed ID: 21787759
[TBL] [Abstract][Full Text] [Related]
38. Functional characterization for polymorphic organic anion transporting polypeptides (OATP/SLCO1B1, 1B3, 2B1) of monkeys recombinantly expressed with various OATP probes.
Takahashi T; Uno Y; Yamazaki H; Kume T
Biopharm Drug Dispos; 2019 Feb; 40(2):62-69. PubMed ID: 30652318
[TBL] [Abstract][Full Text] [Related]
39. Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport.
Kindla J; Müller F; Mieth M; Fromm MF; König J
Drug Metab Dispos; 2011 Jun; 39(6):1047-53. PubMed ID: 21389119
[TBL] [Abstract][Full Text] [Related]
40. Organic anion transporter 3- and organic anion transporting polypeptides 1B1- and 1B3-mediated transport of catalposide.
Jeong HU; Kwon M; Lee Y; Yoo JS; Shin DH; Song IS; Lee HS
Drug Des Devel Ther; 2015; 9():643-53. PubMed ID: 25653502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
